Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Security class unavailable · CUSIP: 68622P109

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,301,232
Percent of class
5.8400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001040188-22-000052
Form type
SC 13G
Filer
Oric Pharmaceuticals, Inc.
CIK
CIK 1796280
Filed
Feb 02, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub